KalVista Pharmaceuticals (KALV) Return on Sales (2014 - 2025)
KalVista Pharmaceuticals recorded quarterly Return on Sales of 0.01% in Q3 2025, down 129.45% quarter-over-quarter from 0.04% in Q2 2025, and up 6.0% year-over-year from 0.01% in Q3 2024.
KalVista Pharmaceuticals' Return on Sales history runs 9 years deep, the most recent figure standing at 0.01% for Q3 2025.
- In Q3 2025, Return on Sales rose 6.0% year-over-year to 0.01%; the TTM figure through Jul 2025 stood at 0.01% (up 7.0% YoY), while the FY2025 annual figure was 0.08%, down 7.0% from the prior year.
- Return on Sales came in at 0.01% for Q3 2025 at KalVista Pharmaceuticals, down from 0.04% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.04% in Q2 2025 to a low of 0.07% in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.00% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.00% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.00% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.00% |
| 10 | KalVista Pharmaceuticals | 1.44 Bn | 1.25 Bn | 56.41 Mn | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | -0.01% |
| Apr 30, 2025 | 0.04% |
| Jul 31, 2024 | -0.07% |
| Apr 30, 2020 | -0.02% |
| Jan 31, 2020 | -0.08% |
| Oct 31, 2019 | -0.02% |
| Jul 31, 2019 | -0.03% |
| Apr 30, 2019 | -0.04% |
| Jan 31, 2019 | -0.02% |
| Oct 31, 2018 | -0.01% |
| Jul 31, 2018 | -0.02% |
| Apr 30, 2018 | -0.01% |
| Jan 31, 2018 | -0.02% |
| Oct 31, 2017 | -0.05% |
| Jul 31, 2017 | -0.57% |
| Apr 30, 2017 | -0.45% |
| Jan 31, 2017 | -0.33% |
| Oct 31, 2016 | -0.20% |
| Jul 31, 2016 | -0.05% |
| Mar 31, 2016 | -9.43% |
| Dec 31, 2015 | -8.08% |
| Sep 30, 2015 | -7.13% |
| Jun 30, 2015 | -8.33% |
| Mar 31, 2015 | -7.41% |
| Dec 31, 2014 | -2.92% |
| Sep 30, 2014 | -3.92% |
| Jun 30, 2014 | -5.04% |
| Mar 31, 2014 | -3.36% |